Average Co-Inventor Count = 6.19
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (14 from 444 patents)
2. Arrowhead Pharmaceuticals, Inc. (4 from 96 patents)
3. Novartis Ag (3 from 3,923 patents)
4. Arrowhead Research Corporation (1 from 18 patents)
22 patents:
1. 12290573 - Modified RNAi agents
2. 12091661 - Organic compositions to treat HSF1-related diseases
3. 12049628 - Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
4. 11406716 - Modified RNAi agents
5. 11286486 - Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
6. 11091761 - Organic compositions to treat HSF1-related diseases
7. 10683501 - Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
8. 10668170 - Modified RNAi agents
9. 10570391 - RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
10. 10287582 - Organic compositions to treat HSF1-related diseases
11. 10208307 - Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
12. 9796974 - Modified RNAi agents
13. 9540643 - Organic compositions to treat HSF1-related diseases
14. 9399775 - RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
15. 9290760 - Modified iRNA agents